
Robert J. Grun
Examiner (ID: 521, Phone: (571)270-5521 , Office: P/1744 )
| Most Active Art Unit | 1744 |
| Art Unit(s) | 4111, 1791, 1744 |
| Total Applications | 931 |
| Issued Applications | 642 |
| Pending Applications | 3 |
| Abandoned Applications | 289 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12472821
[patent_doc_number] => 09989524
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-05
[patent_title] => Immuno imaging agent for use with antibody-drug conjugate therapy
[patent_app_type] => utility
[patent_app_number] => 14/173656
[patent_app_country] => US
[patent_app_date] => 2014-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 20
[patent_no_of_words] => 15022
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14173656
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/173656 | Immuno imaging agent for use with antibody-drug conjugate therapy | Feb 4, 2014 | Issued |
Array
(
[id] => 13853883
[patent_doc_number] => 10188647
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-29
[patent_title] => Combination therapy using P53 activator and c-Met inhibitor
[patent_app_type] => utility
[patent_app_number] => 14/167711
[patent_app_country] => US
[patent_app_date] => 2014-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11014
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 194
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14167711
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/167711 | Combination therapy using P53 activator and c-Met inhibitor | Jan 28, 2014 | Issued |
Array
(
[id] => 11596869
[patent_doc_number] => 09644021
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-09
[patent_title] => 'Bovine fusion antibodies'
[patent_app_type] => utility
[patent_app_number] => 14/152441
[patent_app_country] => US
[patent_app_date] => 2014-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 68565
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14152441
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/152441 | Bovine fusion antibodies | Jan 9, 2014 | Issued |
Array
(
[id] => 14007867
[patent_doc_number] => 10222385
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-03-05
[patent_title] => Methods for discriminating between prostate cancer and a benign prostate-disease
[patent_app_type] => utility
[patent_app_number] => 15/108286
[patent_app_country] => US
[patent_app_date] => 2013-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 10044
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15108286
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/108286 | Methods for discriminating between prostate cancer and a benign prostate-disease | Dec 26, 2013 | Issued |
Array
(
[id] => 10459571
[patent_doc_number] => 20150344586
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-03
[patent_title] => 'Disulfide-Linked Multivalent MHC Class I Comprising Multi-function Proteins'
[patent_app_type] => utility
[patent_app_number] => 14/745170
[patent_app_country] => US
[patent_app_date] => 2013-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 47214
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14745170
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/745170 | Disulfide-linked multivalent MHC class I comprising multi-function proteins | Dec 17, 2013 | Issued |
Array
(
[id] => 12942604
[patent_doc_number] => 09833493
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-12-05
[patent_title] => Method for activating helper T cell
[patent_app_type] => utility
[patent_app_number] => 14/652298
[patent_app_country] => US
[patent_app_date] => 2013-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13199
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14652298
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/652298 | Method for activating helper T cell | Dec 15, 2013 | Issued |
Array
(
[id] => 9537181
[patent_doc_number] => 20140161828
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-12
[patent_title] => 'BCMA ANTIGEN BINDING PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 14/098275
[patent_app_country] => US
[patent_app_date] => 2013-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 53
[patent_figures_cnt] => 53
[patent_no_of_words] => 93749
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14098275
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/098275 | BCMA antigen binding proteins | Dec 4, 2013 | Issued |
Array
(
[id] => 9518206
[patent_doc_number] => 20140154698
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-05
[patent_title] => 'METHODS FOR MEASURING CARCINOEMBRYONIC ANTIGEN'
[patent_app_type] => utility
[patent_app_number] => 14/092036
[patent_app_country] => US
[patent_app_date] => 2013-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 12624
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14092036
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/092036 | Methods for measuring carcinoembryonic antigen | Nov 26, 2013 | Issued |
Array
(
[id] => 9384631
[patent_doc_number] => 20140088113
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-27
[patent_title] => 'METHODS AND KITS THAT IDENTIFY TUMORS RESPONSIVE TO SRC INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 14/090860
[patent_app_country] => US
[patent_app_date] => 2013-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 26677
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14090860
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/090860 | Methods and kits that identify tumors responsive to Src inhibitors | Nov 25, 2013 | Issued |
Array
(
[id] => 13280335
[patent_doc_number] => 10151745
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-12-11
[patent_title] => Methods for determining the risk of acute graft versus host disease
[patent_app_type] => utility
[patent_app_number] => 14/646486
[patent_app_country] => US
[patent_app_date] => 2013-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6056
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14646486
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/646486 | Methods for determining the risk of acute graft versus host disease | Nov 20, 2013 | Issued |
Array
(
[id] => 11075760
[patent_doc_number] => 20160272724
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-22
[patent_title] => 'ANTIBODIES AND FRAGMENTS THEREOF RAISED AGAINST THE ALPHA-3 DOMAIN OF HLA-G PROTEIN, METHODS AND MEANS FOR THEIR PREPARATION, AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/442320
[patent_app_country] => US
[patent_app_date] => 2013-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 16242
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14442320
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/442320 | Antibodies and fragments thereof raised against the alpha-3 domain of HLA-G protein, methods and means for their preparation, and uses thereof | Nov 11, 2013 | Issued |
Array
(
[id] => 10523733
[patent_doc_number] => 09250242
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-02-02
[patent_title] => 'In vitro capture and analysis of circulating tumor cells'
[patent_app_type] => utility
[patent_app_number] => 14/075143
[patent_app_country] => US
[patent_app_date] => 2013-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8401
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14075143
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/075143 | In vitro capture and analysis of circulating tumor cells | Nov 7, 2013 | Issued |
Array
(
[id] => 9616763
[patent_doc_number] => 20140206621
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-24
[patent_title] => 'Cancer Therapy Method'
[patent_app_type] => utility
[patent_app_number] => 14/075276
[patent_app_country] => US
[patent_app_date] => 2013-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6711
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14075276
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/075276 | Cancer therapy method | Nov 7, 2013 | Issued |
Array
(
[id] => 12286270
[patent_doc_number] => 09932412
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-03
[patent_title] => Bispecific antigen binding protein complex and preparation methods of bispecific antibodies
[patent_app_type] => utility
[patent_app_number] => 14/069091
[patent_app_country] => US
[patent_app_date] => 2013-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9316
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14069091
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/069091 | Bispecific antigen binding protein complex and preparation methods of bispecific antibodies | Oct 30, 2013 | Issued |
Array
(
[id] => 9421725
[patent_doc_number] => 20140106376
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-17
[patent_title] => 'METHOD FOR DIAGNOSING GLIOMA AND SCREENING FOR THE THERAPEUTICS OF GLIOMA THROUGH IDENTIFYING PROTEIN RELOCATION'
[patent_app_type] => utility
[patent_app_number] => 14/059283
[patent_app_country] => US
[patent_app_date] => 2013-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 43
[patent_no_of_words] => 7743
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14059283
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/059283 | Method for diagnosing glioma and screening for the therapeutics of glioma through identifying protein relocation | Oct 20, 2013 | Issued |
Array
(
[id] => 10588764
[patent_doc_number] => 09310371
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-04-12
[patent_title] => 'Detection and treatment of cancer'
[patent_app_type] => utility
[patent_app_number] => 14/055396
[patent_app_country] => US
[patent_app_date] => 2013-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 14
[patent_no_of_words] => 18335
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14055396
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/055396 | Detection and treatment of cancer | Oct 15, 2013 | Issued |
Array
(
[id] => 10548531
[patent_doc_number] => 09273142
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-03-01
[patent_title] => 'Glycan-interacting compounds'
[patent_app_type] => utility
[patent_app_number] => 14/050773
[patent_app_country] => US
[patent_app_date] => 2013-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 49739
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14050773
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/050773 | Glycan-interacting compounds | Oct 9, 2013 | Issued |
Array
(
[id] => 9561833
[patent_doc_number] => 20140179547
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-26
[patent_title] => 'Methods For The Generation Of Multispecific And Multivalent Antibodies'
[patent_app_type] => utility
[patent_app_number] => 14/050815
[patent_app_country] => US
[patent_app_date] => 2013-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 16616
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14050815
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/050815 | Methods for the generation of multispecific and multivalent antibodies | Oct 9, 2013 | Issued |
Array
(
[id] => 10346238
[patent_doc_number] => 20150231240
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-20
[patent_title] => 'ANTI-C16ORF54 ANTIBODIES AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/434394
[patent_app_country] => US
[patent_app_date] => 2013-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 94314
[patent_no_of_claims] => 324
[patent_no_of_ind_claims] => 42
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14434394
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/434394 | ANTI-C16ORF54 ANTIBODIES AND METHODS OF USE THEREOF | Oct 8, 2013 | Abandoned |
Array
(
[id] => 9408048
[patent_doc_number] => 20140099300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-10
[patent_title] => 'METHODS FOR PREDICTING AND IMPROVING THE SURVIVAL OF GASTRIC CANCER PATIENTS'
[patent_app_type] => utility
[patent_app_number] => 14/044792
[patent_app_country] => US
[patent_app_date] => 2013-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 53
[patent_figures_cnt] => 53
[patent_no_of_words] => 36627
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14044792
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/044792 | METHODS FOR PREDICTING AND IMPROVING THE SURVIVAL OF GASTRIC CANCER PATIENTS | Oct 1, 2013 | Abandoned |